Population pharmacokinetic and exposure-response analyses for efficacy and safety of risankizumab in subjects with active Crohn's disease

被引：0
|
作者：
Suleiman, A. [1 ]
Goebel, A. [1 ]
Bhatnagar, S. [2 ]
D'Cunha, R. [2 ]
Liu, W. [2 ]
Pang, Y. [2 ]
机构：
[1] Clin Pharmacol & Pharmacometr, AbbVie, Ludwigshafen, Germany
[2] Clin Pharmacol & Pharmacometr, AbbVie, N Chicago, IL USA
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P574
引用
收藏
页码：I514 / I516
页数：4
相关论文
共 50 条
  • [31] Pharmacokinetic and exposure-response analyses for extrapolation of efficacy of adalimumab in adolescent patients with hidradenitis suppurativa
    Nader, A.
    Kluender, B.
    Kwatra, N. V.
    Wegzyn, C.
    Mostafa, N. M.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 : 29 - 29
  • [32] Adjunctive Perampanel In Paediatric Patients With Epilepsy: Population Pharmacokinetic (PK) And Exposure-Response Analyses
    Majid, O.
    Reyderman, L.
    Ferry, J.
    Hussein, Z.
    EPILEPSIA, 2019, 60 : 107 - 108
  • [33] Population pharmacokinetic and exposure-response analysis of apremilast in Japanese subjects with moderate to severe psoriasis
    Okubo, Yukari
    Ohtsuki, Mamitaro
    Komine, Mayumi
    Imafuku, Shinichi
    Kassir, Nastya
    Petric, Rosemary
    Nemoto, Osamu
    JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1652 - 1664
  • [34] Population Pharmacokinetic Modeling and Exposure-Response Analysis for Aripiprazole Once Monthly in Subjects With Schizophrenia
    Wang, Xiaofeng
    Raoufinia, Arash
    Bihorel, Sebastien
    Passarell, Julie
    Mallikaarjun, Suresh
    Phillips, Luann
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (02): : 150 - 164
  • [35] Adjunctive Perampanel in Pediatric Patients with Epilepsy: Population Pharmacokinetic (PK) and Exposure-Response Analyses
    Majid, Oneeb
    Reyderman, Larisa
    Ferry, Jim
    Hussein, Ziad
    NEUROLOGY, 2019, 92 (15)
  • [36] Population pharmacokinetic and exposure-response safety analyses of mecbotamab vedotin (BA3011) in patients with advanced solid tumors
    Shen, Guoxiang George
    Briggs, Emily
    Crass, Ryan
    Karumanchi, Sravan
    Boyle, William J.
    Baker, Michael G.
    Martin, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Population Pharmacokinetic and Exposure-Response Analyses of Prasugrel in Pediatric Patients with Sickle Cell Anemia
    Moser, Brian A.
    LaBell, Elizabeth S.
    Chigutsa, Emmanuel
    Jakubowski, Joseph A.
    Small, David S.
    CLINICAL PHARMACOKINETICS, 2018, 57 (02) : 243 - 254
  • [38] Cabozantinib exposure-response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma
    Linh Nguyen
    Chapel, Sunny
    Tran, Benjamin Duy
    Lacy, Steven
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (06) : 577 - 589
  • [39] Exposure-response relationships for efficacy and safety of risankizumab in patients with moderate to severe plaque psoriasis: Integrated analyses of phase 2 and 3 clinical trials
    Khatri, Amit
    Suleiman, Ahmed A.
    Polepally, Akshanth R.
    Othman, Ahmed A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB209 - AB209
  • [40] Exposure-response analyses of tigecycline tolerability in healthy subjects
    Passarell, Julie
    Ludwig, Elizabeth
    Liolios, Kathryn
    Meagher, Alison K.
    Grasela, Thaddeus H.
    Babinchak, Timothy
    Ellis-Grosse, Evelyn J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 65 (02) : 123 - 129
12345